Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial
Bharucha KN et al. J Rheumatol 2018. doi: 10.3899/jrheum.170326
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.